Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

ALK7 Signaling Manifests a Homeostatic Tissue Barrier That Is Abrogated during Tumorigenesis and Metastasis.

Developmental cell | 2019

Herein, we report that the TGFß superfamily receptor ALK7 is a suppressor of tumorigenesis and metastasis, as revealed by functional studies in mouse models of pancreatic neuroendocrine and luminal breast cancer, complemented by experimental metastasis assays. Activation in neoplastic cells of the ALK7 signaling pathway by its principal ligand activin B induces apoptosis. During tumorigenesis, cancer cells use two different approaches to evade this barrier, either downregulating activin B and/or downregulating ALK7. Suppressing ALK7 expression additionally contributes to the capability for metastatic seeding. ALK7 is associated with shorter relapse-free survival of various human cancers and distant-metastasis-free survival of breast cancer patients. This study introduces mechanistic insights into primary and metastatic tumor development, in the form of a protective barrier that triggers apoptosis in cells that are not "authorized" to proliferate within a particular tissue, by virtue of those cells expressing ALK7 in a tissue microenvironment bathed in its ligand.

Pubmed ID: 31063757 RIS Download

Additional research tools detected in this publication

Associated grants

  • Agency: CIHR, Canada

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Fiji (tool)

RRID:SCR_002285

Software package as distribution of ImageJ and ImageJ2 together with Java, Java3D and plugins organized into coherent menu structure. Used to assist research in life sciences.

View all literature mentions

PRISM (tool)

RRID:SCR_005375

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on May 5,2022.Tool that predicts interactions between transcription factors and their regulated genes from binding motifs. Understanding vertebrate development requires unraveling the cis-regulatory architecture of gene regulation. PRISM provides accurate genome-wide computational predictions of transcription factor binding sites for the human and mouse genomes, and integrates the predictions with GREAT to provide functional biological context. Together, accurate computational binding site prediction and GREAT produce for each transcription factor: 1. putative binding sites, 2. putative target genes, 3. putative biological roles of the transcription factor, and 4. putative cis-regulatory elements through which the factor regulates each target in each functional role.

View all literature mentions

CRAN (tool)

RRID:SCR_003005

Network of ftp and web servers around world that store identical, up to date, versions of code and documentation for R. Package archive network for R programming language.

View all literature mentions

Inhibin beta B antibody (antibody)

RRID:AB_2049819

This polyclonal targets Human Inhibin beta B

View all literature mentions

β-Actin Antibody (antibody)

RRID:AB_330288

This polyclonal targets β-actin

View all literature mentions

Cleaved PARP antibody [E51] (antibody)

RRID:AB_777102

This monoclonal targets Cleaved PARP antibody [E51]

View all literature mentions

HSP 90alpha/beta (F-8) (antibody)

RRID:AB_675659

This monoclonal targets HSP90AA1, HSP90AB1, HSP90B1

View all literature mentions

SAPK/JNK Antibody (antibody)

RRID:AB_2250373

This polyclonal targets SAPK/JNK

View all literature mentions

Phospho-MKK7 (Ser271/Thr275) Antibody (antibody)

RRID:AB_2250408

This unknown targets MKK7, phospho (Ser271 / Thr275)

View all literature mentions

p38 MAPK (D13E1) XP Rabbit mAb (antibody)

RRID:AB_10999090

This monoclonal targets p38 MAPK (D13E1) XP Rabbit mAb

View all literature mentions

Phospho-SEK1/MKK4 (Ser257/Thr261) Antibody (antibody)

RRID:AB_2297420

This unknown targets SEK1 / MKK4, phospho (Ser257 / Thr261)

View all literature mentions

Phospho-Smad2 (Ser465/467) (138D4) Rabbit mAb (antibody)

RRID:AB_490941

This monoclonal targets Phospho-Smad2 (Ser465/467) (138D4) Rabbit mAb

View all literature mentions

Smad2 (D43B4) XP Rabbit mAb (antibody)

RRID:AB_10626777

This monoclonal targets Smad2 (D43B4) XP Rabbit mAb

View all literature mentions

GFAP antibody (antibody)

RRID:AB_880202

This polyclonal targets Mouse GFAP

View all literature mentions

Chromogranin A antibody (antibody)

RRID:AB_301704

This polyclonal targets Chromogranin A antibody

View all literature mentions

Luciferase Antibody (antibody)

RRID:AB_10000585

This unknown targets Luciferase

View all literature mentions

Activin A Receptor Type IC antibody - Aminoterminal end (antibody)

RRID:AB_1267623

This polyclonal targets Human Activin A Receptor Type IC - Aminoterminal end

View all literature mentions

Beta-TC-3 (cell line)

RRID:CVCL_0172

Cell line Beta-TC-3 is a Transformed cell line with a species of origin Mus musculus (Mouse)

View all literature mentions

STC-1 (cell line)

RRID:CVCL_J405

Cell line STC-1 is a Cancer cell line with a species of origin Mus musculus

View all literature mentions

MDA231-LM2-4175 (cell line)

RRID:CVCL_5998

Cell line MDA231-LM2-4175 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions